CATANZARO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 4.225
AS - Asia 2.622
EU - Europa 1.509
SA - Sud America 444
AF - Africa 353
Continente sconosciuto - Info sul continente non disponibili 88
OC - Oceania 33
Totale 9.274
Nazione #
US - Stati Uniti d'America 3.964
SG - Singapore 974
CN - Cina 543
IT - Italia 457
BR - Brasile 295
VN - Vietnam 269
HK - Hong Kong 232
DE - Germania 109
FI - Finlandia 107
PL - Polonia 103
FR - Francia 102
SE - Svezia 94
IN - India 91
GB - Regno Unito 71
BD - Bangladesh 59
CA - Canada 52
UA - Ucraina 51
NL - Olanda 46
IQ - Iraq 42
TR - Turchia 42
RU - Federazione Russa 37
AR - Argentina 32
PH - Filippine 31
EC - Ecuador 29
MX - Messico 27
RO - Romania 27
ZA - Sudafrica 26
ES - Italia 25
ID - Indonesia 25
JP - Giappone 24
AT - Austria 21
CO - Colombia 20
CZ - Repubblica Ceca 20
SA - Arabia Saudita 20
CH - Svizzera 19
JM - Giamaica 18
CR - Costa Rica 17
KR - Corea 17
BE - Belgio 16
IE - Irlanda 16
PK - Pakistan 16
UZ - Uzbekistan 16
VE - Venezuela 16
AE - Emirati Arabi Uniti 15
BB - Barbados 15
BZ - Belize 15
JO - Giordania 15
MA - Marocco 15
MY - Malesia 15
SI - Slovenia 15
AZ - Azerbaigian 14
KE - Kenya 14
PT - Portogallo 14
TH - Thailandia 14
AO - Angola 13
DO - Repubblica Dominicana 13
LB - Libano 13
NP - Nepal 13
TZ - Tanzania 13
YT - Mayotte 13
BF - Burkina Faso 12
CL - Cile 12
DZ - Algeria 12
EE - Estonia 12
GM - Gambi 12
MK - Macedonia 12
RS - Serbia 12
TT - Trinidad e Tobago 12
XK - ???statistics.table.value.countryCode.XK??? 12
AL - Albania 11
EG - Egitto 11
ET - Etiopia 11
RE - Reunion 11
AU - Australia 10
CU - Cuba 10
KH - Cambogia 10
LU - Lussemburgo 10
UG - Uganda 10
BA - Bosnia-Erzegovina 9
BG - Bulgaria 9
BJ - Benin 9
CM - Camerun 9
CW - ???statistics.table.value.countryCode.CW??? 9
GE - Georgia 9
GH - Ghana 9
HN - Honduras 9
HR - Croazia 9
IS - Islanda 9
LY - Libia 9
NI - Nicaragua 9
PE - Perù 9
PS - Palestinian Territory 9
PY - Paraguay 9
SO - Somalia 9
TJ - Tagikistan 9
ZW - Zimbabwe 9
AD - Andorra 8
BO - Bolivia 8
CI - Costa d'Avorio 8
GF - Guiana Francese 8
Totale 8.853
Città #
Ashburn 571
Singapore 568
San Jose 512
Fairfield 295
Chandler 217
Hong Kong 208
Ann Arbor 159
Beijing 158
Woodbridge 153
Houston 138
Cambridge 135
Padova 133
Wilmington 102
Ho Chi Minh City 101
Santa Clara 100
Boardman 94
Seattle 90
Helsinki 71
Bytom 69
Los Angeles 65
Princeton 60
Hanoi 59
Medford 58
New York 56
Des Moines 52
Lauterbourg 51
Munich 36
Malo 31
Nanjing 31
Dallas 28
São Paulo 28
Chennai 27
Roxbury 27
Warsaw 26
Baghdad 24
San Diego 24
Tokyo 22
Council Bluffs 21
Milan 21
Buffalo 20
Brooklyn 17
Chicago 16
Da Nang 16
New Kensington 16
Orem 16
Washington 16
Amman 15
Guangzhou 15
Dublin 14
Phoenix 14
Tashkent 14
Baku 13
Bridgetown 13
Johannesburg 13
Kingston 13
Poplar 13
Rome 13
Istanbul 12
Montreal 12
Redondo Beach 12
Rio de Janeiro 12
Atlanta 11
Nairobi 11
Nanchang 11
New Delhi 11
San José 11
Shenyang 11
Turku 11
Amsterdam 10
Belo Horizonte 10
Catanzaro 10
Dar es Salaam 10
Hefei 10
Kampala 10
Mamoudzou 10
Phnom Penh 10
Vienna 10
Accra 9
Basingstoke 9
Brussels 9
Denver 9
Harare 9
Havana 9
Managua 9
Mexico City 9
Porto Alegre 9
Pristina 9
Quito 9
Shanghai 9
Tallinn 9
Abidjan 8
Andorra la Vella 8
Belgrade 8
Boston 8
Dushanbe 8
Frankfurt am Main 8
Guayaquil 8
Haiphong 8
Hebei 8
Jinan 8
Totale 5.300
Nome #
Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage 363
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells 309
Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death 268
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy 257
Further assessment of Salvia haenkei as an innovative strategy to counteract skin photo-aging and restore the barrier integrity 256
A fixed combination of probiotics and herbal extracts attenuates intestinal barrier dysfunction from inflammatory stress in an in vitro model using Caco-2 cells. 255
Effect of Quercetin on Cell Cycle and Cyclin Expression in Ovarian Carcinoma and Osteosarcoma Cell Lines 253
Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T>C mitochondrial tRNAIle mutation causing hypertrophic cardiomyopathy. 241
Anti-inflammatory activity of Serenoa Repens on human prostate adenocarcinoma cells 222
Chlorogenic Acid Interaction with Cisplatin and Oxaliplatin: Studies in Cervical Carcinoma Cells 213
Protective effects of ψ taraxasterol 3-O-myristate and arnidiol 3-O-myristate isolated from Calendula officinalis on epithelial intestinal barrier 205
Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress 204
Metabolic and mitochondrial remodelling in cisplatin resistance: studies on ovarian cancer cells and derived cytoplasmic hybrids 201
Cell cycle control by natural phenols in cisplatin-resistant cell lines. 200
Attività antinfiammatoria e antiossidante di Boswellia serrata in un modello di epitelio intestinale in vitro. 200
Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression 192
Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2 175
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report 167
Overcome cisplatin -resistance by targetin glucose-6-phosphate dehydrogenase with the combination of liposomal cisplatin and 6-amino nicotinamide 167
Anti-ageing activity of Salvia haenkei in an in vitro epidermal model 166
Metabolic Profile of Cisplatin-resistant Phenotype - Studies in Ovarian Carcinoma Cell Lines 158
Metabolic profile of cisplatin-resistant phenotype: studies in ovarian carcinoma cell lines. 154
Silybin as a new tool to counteract doxorubicin resistance by targeting glucose uptake 149
Anti-senescence activity of Salvia Haenkei on a skin cellular model 145
Rho0 cells and metabolomic approach to exploit mechanism of resistance to cisplatin in ovarian cancer cell lines. 143
Silybin, curcumin and quercetin as metabolic modulators in human resistant cancer cells 143
Natural compounds as metabolic modulators in resistant cancer cells models 139
Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses CisplatinResistance: new pharmacological approach using Cisplatin liposome and 6-amino nicotinamide combination 137
Role of mitochondria in cisplatin-resistance phenomena 136
Mitochondria as cisplatin targets: new apporach to counteract resistance mechanism 135
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 135
Imbalance of mitochondrial "shaping proteins" and cisplatin resistance 134
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 134
Insight into mitochondrial and metabolic asset of cisplatin resistant ovarian cancer cells. 130
Effects of genistein on Leber’s hereditary optic neuropathy (LHON) mitochondrial metabolism. 129
Potential effect of Salvia Haenkey on in vitro wound healing 129
Targeting glucose-6-phosphate dehydrogenase by 6-amino nicotinamide in combination with liposomal cisplatin as a strategy to sensitize ovarian resistant cancer cells 129
Mitochondrial remodeling involved in cisplatin resistance 126
Quercetin and Cisplatin combined treatment alter cell cycle and sensitize resistant cancer cell lines 125
Cannabis Sativa modulates epithelial permeability in an in vitro intestinal inflammation model 124
Mitochondrial alterations involved in cisplatin resistance phenomena 122
Molecular mechanism of resistance to cisplatin: study of metabolism in ovarian cancer cells. 117
Lipid-metabolic reprogramming in ovarian carcinoma cell lines resistant to cisplatin 117
SILYBIN: A NATURAL COMPOUND ABLE TO OVERCOME DOXORUBICIN RESISTANCE PHENOMENA 116
Targeting glucose-6-phosphate dehydrogenase with a combination of liposomal cisplatin and 6-amino nicotinamide as new strategy to overcome cisplatin-resistance 115
Natural compounds as metabolic modulators in resistant cancer models 113
Natural polyphenol sensitize cancer cells to cisplatin effect on cell cycle 112
Calu-3 cells as in vitro model of bronchial epithelium for pharmacological studies of natural compounds 109
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 108
Silybin chemosensitize doxorubicin-resistant cells by targeting GLUT1 108
Oxidative stress and metabolic reprogramming: study of pharmacological targets in cellular models of mithocondrial disease. 99
Antioxidant and anti-inflammatory activities of Cannabis Sativa in epithelial intestinal cell 99
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 99
Cannabis Sativa L. modulates epithelial permeability in an in vitro intestinal inflammation model 97
Mitochondria on Cisplatin resistance: studies on ovarian cancer cells. 93
Natural compounds as metabolic modulators in resistant cancer cell models 91
Mithocondria defect and cisplatin resistance: relationships on ovarian cancer cells. 81
Natural polyphenols as chemosensitizer: studies in resistant cancer cells. 78
Silybin glycolysis inhibitor as promising agent in chemotherapy 77
Natural polyphenols chemosensitize cisplatin-resistant cells through cell cycle modulation 75
Totale 9.274
Categoria #
all - tutte 27.101
article - articoli 13.404
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.505


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022552 0 121 38 16 28 61 21 36 42 10 25 154
2022/2023521 105 34 4 38 125 68 5 34 73 2 22 11
2023/2024388 21 48 43 32 37 62 21 40 3 6 37 38
2024/20251.335 9 64 64 62 210 25 90 138 79 54 208 332
2025/20264.775 294 393 534 786 520 224 508 420 524 310 191 71
2026/2027150 146 4 0 0 0 0 0 0 0 0 0 0
Totale 9.274